4.3 Review

Psoriatic arthritis: complexities, comorbidities and implications for the clinic

期刊

EXPERT REVIEW OF CLINICAL IMMUNOLOGY
卷 12, 期 4, 页码 405-416

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1586/1744666X.2016.1139453

关键词

psoriatic arthritis; treatment; comorbidities

资金

  1. Abbvie
  2. Pfizer
  3. BMS

向作者/读者索取更多资源

Psoriatic arthritis (PsA) is a chronic immune-mediated inflammatory disease that affects peripheral joints, entheses and axial sites in addition to both skin and nails. There is considerable evidence to support the assertion that PsA is actually a multisystem disease. Contrary to earlier beliefs, PsA is not only common but also a potentially deforming and disabling disease. In addition to the characteristic extra-articular features, such as uveitis and inflammatory bowel disease, patients with PsA may also suffer from co-existing diseases, referred to as comorbidities. The presence of both extra-articular manifestations and comorbidities may have consequences for the treatment, prognosis and outcome of the disease, which frequently go unrecognized or undertreated. The following review article describes the complexities and comorbidities of PsA as well as their implications for the clinic.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据